Implication of Oxidative Stress in the Human Gastro-Duodenal Pathology Induced by Helicobacter Pylori by MARTURA, Simona et al.
 152 
Bulletin UASVM, Veterinary Medicine 66(1)/2009 
ISSN 1843-5270; Electronic ISSN 1843-5378 
 
 
Implication of Oxidative Stress in the Human Gastro-Duodenal Pathology 
Induced by Helicobacter Pylori 
 
Simona MARTURA1), Petru A. MIRCEA1), Simona VALEAN1), Romeo CHIRA1), 
Adrian CATINEAN1),  Adriana MURESAN2), Doina DAICOVICIU2), Soimita SUCIU2) 
 
1)
 Medical Clinic I, Cluj-Napoca, Romania, restemans@yahoo.com 
2) Dept. of Physiology, Univ. Med. Pharm. Cluj-Napoca, Romania 
 
 Abstract. Recent research suggests that oxidative stress plays an important role in the 
development of gastroduodenal diseases associated with Helicobacter pylori. We investigated the 
variation of oxidative stress parameters following administration of antiulcer therapy in 79 patients 
with duodenal ulcer and chronic gastritis respectively, infected with Helicobacter pylori. Serum and 
tissue oxidative stress parameters were significantly modified in the period between diagnosis and 
healing of lesions. The results obtained indicated an increased production of oxygen reactive species at 
both serum and gastric tissue levels in the patients diagnosed with gastro-duodenal peptic disease. The 
production was directly correlated with the severity of the injury. In parallel a deficit of the 
physiological production of endogenous antioxidants was found, also correlated with the severity of 
the injuries. Antiulcer treatment led to the improvement of the antioxidant status, healing of lesions 
and eradication of the infection; a significant decrease of the pro-oxidant compounds in the blood and 
in the tissue was also found, especially at the level of the antral gastric tissue; they were more marked 
in the patients with duodenal ulcer as compared to those with chronic gastritis. 
 





 There is a growing concern regarding the involvement of oxygen reactive species 
(ROS) in the etiology and pathophysiology of human diseases, among which gastrointestinal 
inflammations and peptic ulcer. The role of ROS in most diseases and the protective effects of 
products with antioxidant potential on the affected tissues represent subjects of high interest 
(Repetto and Llesuy, 2002). The human body has developed a number of endogenous 
antioxidant systems in order to fight ROS. It is also known that bacterial products and 
inflammation affect the self-protective capacity of the gastric cells against ROS damage 
(Natale et al., 2004). The alterations at the antioxidant molecular level may represent an 
important factor in the etiology of gastro-duodenal ulcer (Demir et al., 2003). In the 
gastrointestinal tract the inflammatory process is the key component of the defense of the 
mucosa against exogenous and endogenous factors. Gastro-duodenal mucosa is able to resist 
the digestion by the endogenous substances we secrete in order to process food. The so called 
“mucosal defense” depends on several factors and it is controlled by a large number of 
substances, many of them classically considered as inflammation mediators (Martin and 
Wallace, 2006). Gastric mucosa has an antioxidant defense mechanism that eliminates the 
peroxides, free radicals and superoxides generated (Jainu et al., 2006). Peri-ulcerous 
microcirculation plays an important role in the healing process by supplying oxygen and 
nutrients, and removing toxic substances, most probably ROS, from the ulcerous area 
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(Brzozowska et al., 2004). The investigation of the status of free radicals may be performed 
by three ways: measuring the production of radicals (pro-oxidant status), measuring the 
defense capacity (antioxidant status), and measuring the extent of specific biochemical injury 
resulted from the imbalance between antioxidant and pro-oxidant (Favier, 2006). The 
presence of Helicobacter pylori is not considered a disease in itself, but it represents a 
condition influencing the relative risk of developing clinical disorders of the upper 
gastrointestinal tract and possible hepato-biliary tract. Both gastric and duodenal ulcer are 
closely associated with the Helicobacter pylori infection. Worldwide reports on the first 
decade after diagnosis of the infection show that about 95% of duodenal ulcers and 85% of 
gastric ulcers occur in the presence of Helicobacter pylori (Kusters et al., 2006). Recent 
studies have suggested that free oxygen radicals have a role in the development of 
Helicobacter pylori- related gastro-duodenal diseases, including gastric cancer (Phull et al., 
1996). Oxidative stress may intervene in the Helicobacter pylori- related epithelial cell 
proliferation, enhanced apoptosis and increased oxidative alteration of the DNA. The 
evidence includes increased ROS levels determined in the mucosa of infected patients. Once 
activated, the phagocytes releasing ROS, recruited at the level of gastric mucosa during the 
infection, represent a source of oxidative stress; other studies have demonstrated that 
Helicobacter pylori itself generates ROS, which accumulate in the gastric epithelial cells 
(Ding et al., 2007). 
 
 
MATERIALS AND METHODS 
 
The study was carried out in the period 2004-2008 in 79 patients. They had a clinical, 
endoscopic and patho-morphological diagnosis of duodenal ulcer (DU) or chronic gastritis 
(CG), and infection with Helicobacter pylori; the latter was diagnosed based on the 
histological method and the urease test on bioptic samples collected from the antrum. The 
patients included in the study were selected from the patients admitted and/or examined at the 
Gastroenterology Unit of Medical Clinic I of Cluj-Napoca. Informed consent was obtained 
from all the patients. 
The main objective of the study was to follow up the variation of the parameters of 
oxidative stress after antiulcer therapy; other objective included investigation of clinical 
symptoms, endoscopic and histopathological evolution of the gastric tissue. 
Inclusion criteria: age between 18- 60 years and no other major diseases (e.g. liver 
cirrhosis, COPD, heart disease, stroke, cancer etc.) that could have influenced even more the 
parameters of oxidative stress, the evolution of the disease studied, or the therapeutic 
response. 
Exclusion criteria: smokers, alcohol drinkers, patients on NSAIDs or anticoagulant 
drugs, with multiple drug allergy, cholecystectomy, recent antiulcer treatment, workers in 
toxic environment, or those presenting one of the following at the endoscopic examination: 
complicated/resistant ulcers, atrophic gastritis, reflux esophagitis, gastric dysplasia, 
metaplasia or neoplasm. 
The patient groups were as follows: 
- Group I – 42 patients with duodenal ulcer and Hp infection (DU Hp+) 
- Group II – 37 patients with chronic gastritis and Hp infection (CG Hp+) 
Treatment included proton pump inhibitors: Omeprazole 2 x 20 mg/day for 2 weeks 
for gastritis, and 6 weeks for duodenal ulcers. For the Helicobacter pylori infection a  
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combination of two antibiotics was given for the first 7 days of the antisecretory treatment: 
Amoxicillin 2 x 1000 mg/day and Clarithromycin 2 x 500 mg/day. 
In every patient biological samples (blood and tissue) were harvested before starting 
the therapy and 7 days after it finished. About 10 ml venous blood were collected, centrifuged 
immediately for 5 minutes at 3500 rotations/min. Plasma thus obtained was frozen and kept at 
- 800C till examined for oxidative stress parameters. The tissue was collected from the gastric 
antrum; the bioptic samples were submitted to the urease test for the histopathological 
examination and determination of oxidative stress parameters. 
Oxidative stress indicators determined: 
- Pro-oxidant markers – blood: malonealdehyde (MAD) and carbonylated proteins 
(CP); tissue: carbonylated proteins (CP) 
- Antioxidant markers – blood: hydrogen donors (HD) and thiol groups (SH); tissue: 
hydrogen donors (HD). 
Methods of determination of oxidative stress: 
Malonealdehyde was determined according to Conti’s fluorescence dosage. Serum 
concentrations were expressed in nmol/ml, and gastric tissue concentrations in nmol/mg 
protein (Conti, et al., 1991). 
Carbonilated proteins were assessed using Rezsnik’s method. Results were expressed 
in nmol/ml and nmol/mg protein for the serum and gastric tissue respectively (Reznick and 
Packer, 1994). 
The hydrogen donors capacity was determined using Janaszewska’s dosage method. 
The results were expressed in percentages of free radical inhibition both in the serum and in 
the gastric tissue (Janaszewska and Bartosz, 2002). 
Total content of thiol groups (sulphhydril) was determined using Hu’s method, with 
values expressed as µmol/mg protein for the gastric tissue (Hu, 1994). 
Statistical processing of the results was performed using the SPSS 13 package. 
Statistical difference between means was based on the Student “t” test. Two aspects 
wereunder scrutiny: descriptive analysis of data and the significance of the difference between 






The clinical evolution of the patients was good in all the cases, symptoms subsided 
within 3-4 days from initiation of therapy. Endoscopic and patho-morphological healing was 
obtained in 100% of the cases. 















Tab. 1.  




































Fig. 1. Pre- and post- treatment variation of serum malonaldehyde 
 
Serum malonaldehyde decreased significantly in all the patients after treatment (fig.1). 
  














Pre-th. 1.4521 3.2824 29.050 0.3093 5.1570 27.573 
Mean 
Post-th. 1.3169 2.98 32.697 0.3279 3.5497 31.983 




Post-th. 0.1571 1.3889 8.942 0.0922 1.4851 9.390 
Pre-th. 1.4378 2.4638 31.332 0.3297 5.1945 28.3486 
Mean 
Post-th 1.3235 2.1835 34.481 0.3365 3.6105 32.3270 





Post-th. 0.1661 1.1845 8.747 0.1074 1.4511 9.559 
Serum indicators Tissue indicators 
Group 
MAD CP HD SH CP HD 
I 0.000 0.001 0.022 0.245 0.000 0.016 


















Serum carbonylated proteins decreased significantly in group I; no significant changes 
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Fig. 3. Pre- and post- treatment variation of serum hydrogen donors 
 
Hydrogen donors increased significantly in the patients with duodenal ulcers; it did not 









Fig. 4. Pre- and post- treatment variation of serum thiol groups 
 

















Fig. 5. Pre- and post- treatment variation of carbonylated proteins in the gastric tissue 
 
 
A highly significant decrease of carbonylated proteins in the gastric tissue was noted 









Fig. 6. Pre- and post- treatment variation of hydrogen donors in the gastric tissue 
 




 This study showed that serum and tissue oxidative stress parameters were significantly 
modified after antiulcer treatment, over the period between the time of diagnosis and the time 
of healing. The results obtained indicate an increased ROS production both at serum and 
gastric tissue levels in the patients diagnosed with gastro-duodenal peptic disease. This 
production is higher with higher severity of the injury. In parallel a deficit of physiological 
production of endogenous antioxidants was found, directly correlated with the severity of the 
morphopathological findings. Anti-seceretory treatment included omeprazole, due to its 
efficiency in the deep suppression of acid secretion (Gillen, et al.,1999). Previous studies have 
demonstrated that it also inhibits the respiratory explosion of polymorphonuclear cells in 
vitro, thus also having an antioxidant potential (Natale, et al., 2004). The results obtained after 
therapy evidenced a significant reduction of pro-oxidant compounds in the blood and in the 
gastric tissue; they were more marked in the patients with duodenal ulcer. These results are 
probably correlated with the level of gastric acidity, which, in excess, may enhance the 
severity of the aggression on the gastric mucosa and therefore the increase of oxidative stress. 
Before starting the antiulcer therapy we found low values of serum and tissue endogenous 






who have showed that glutathione (GSH) an important endogenous antioxidant, are 
significantly reduced in the patients infected with Helicobacter pylori as compared to non-
infected ones (Arend et al., 2005). Similar findings have been reported by Naito et al. in 2002 
regarding the effects of Helicobacter pylori on the glutathione content of the gastric mucosa; 
they have shown that GSH levels are significantly lower in the patients infected with 
Helicobacter pylori than in those without infection (Naito and Yoshikawa, 2002). Moreover, 
Obst et al. have demonstrated that Helicobacter pylori directly stimulates the ROS production 
in the gastric epithelial cells and reduces GSH cellular levels (Obst et al., 2000). A marked 
decrease of the serum and tissue antioxidant levels was found in the patients with ulcer. In 
these patients the depletion of antioxidants in the serum and the mucosa was much more 
severe than in the patients with gastritis and Helicobacter pylori infection, but free of ulcer 





 We may conclude that in the patients with ulcer and gastritis infected with 
helicobacter pylori, therapy significantly improves the oxidant-antioxidant balance. These 
changes occur both at serum and tissular levels. Antiulcerous therapy improves the 
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